Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$4.20
+3.19%
Mkt Cap $43.23M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+376.2%
Consensus $20.00 vs current $4.20
NASDAQ·Healthcare·Biotechnology
$4.20
+3.19%
Mkt Cap $43.23M
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+376.2%
Consensus $20.00 vs current $4.20